Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D003854:Deoxyribonucleotides / Q000378:metabolism; D005260:Female; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D062385:Hydroxybenzoates / Q000494:pharmacology; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D012262:Ribonucleoside Diphosphate Reductase / Q000037:antagonists & inhibitors*; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D003854:Deoxyribonucleotides; D006877:Hydroxamic Acids; D062385:Hydroxybenzoates; D012313:RNA; D004247:DNA; D012264:Ribonucleotide Reductases; D012262:Ribonucleoside Diphosphate Reductase